Evidence map›Paper›PMID 37634058›Full record

ArticleAnnals of medicine2023

Validation of the 2011 and 2016 American college of rheumatology diagnostic criteria for fibromyalgia in a Chinese population.

Juan Jiao, Zeng-Yu Cheng, Yu-Ya Xiao, Hui Wang, Yong-Feng Zhang, Ya-Yun Zhao, Yuan Jia

Registry-linked trialAbstract readValidation Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Annals of medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03381131 (The Chinese Version of the Modified American College of Rheumatology), which is not on this map. Cited by 6 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03381131 completednot on this map

The Chinese Version of the Modified American College of Rheumatology (ACR) Diagnostic Criteria for Fibromyalgia and the Fibromyalgia Impact Questionnaire: Reliability and Validity

Typeobservational_patient_registrySponsorGuang'anmen Hospital of China Academy of Chinese Medical SciencesRan2018 to 2021Enrolled327ConditionsChinese Version, Fibromyalgia, Diagnosis, Fibromyalgia Impact Questionnaire
3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Observational
  6. [Effects of overweight and obesity on symptoms, overall condition and quality of life in patients with fibromyalgia syndrome].Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Juan JiaoRheumatology Department, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Zeng-Yu ChengRheumatology Department, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Yu-Ya XiaoRheumatology Department, Shenzhen Traditional Chinese Medicine Hospital, Shenzhen, China.
Hui WangDepartment of Rheumatology, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
Yong-Feng ZhangDepartment of Rheumatology and Clinical Immunology, Beijing Chao Yang Hospital, Capital Medical University, Beijing, China.
Ya-Yun ZhaoRheumatology Department, Hebei Hospital of Traditional Chinese Medicine, Shijiazhuang, China.
Yuan JiaDepartment of Rheumatology and Immunology, Peking University People's Hospital & Beijing Key Laboratory for Rheumatism Mechanism and Immune Diagnosis, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo provide a foundation for clinical diagnosis, epidemiological investigation and intervention trials, we examined the reliability and validity of the American College of Rheumatology (ACR) 2011 and 2016 survey diagnostic criteria among Chinese patients based on the fibromyalgia severity (FS) scale.

methodsIn this study, 200 fibromyalgia patients diagnosed according to the 1990 criteria (1990c) were matched with rheumatoid arthritis (RA) patients based on age and gender. The FS scale score and its subscales were examined to determine their correlations with the revised fibromyalgia impact questionnaire (FIQR). Receiver operator characteristic (ROC) analysis was performed, and test-retest reliability, internal consistency, and construct validity were examined.

resultsThe area under the curve (AUC) for the ACR 2011c and 2016c was 0.870 and 0.845, respectively, and the sensitivity and specificity were 78.0% and 96.0% for the 2011c and 70.5% and 98.5% for the 2016c, respectively. The FS scale and its subscales were confirmed to exhibit good internal consistency, and they were significantly correlated with the FIQR, thereby indicating adequate construct validity. Using a lower cutoff value 11 points for the FS scale score based on the generalized pain requirement might be a more effective approach in the Chinese population; this approach yielded an AUC of 0.923 and a sensitivity of 87.0% and specificity of 97.5%.

conclusionThe 2011c and 2016c are reliable instruments for diagnosing fibromyalgia patients in China. The FS scale could be a valid tool to assist in fibromyalgia diagnosis, and a cutoff value 11 points is more suitable in Chinese patients.

trial registrationClinicalTrials.gov ID: NCT03381131.

Indexed as

FibromyalgiaRheumatologyEast Asian PeopleHumansPainPatient SelectionReproducibility of Results

Identifiers

PMID37634058
PMCPMC10461495

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.